EUVIMEDEUVIMED entdecken
Multizentrische StudieVideo/AudioKlinische StudieOpen Access · CC BY 4.0

Endoscopic eradication therapy with multifocal cryoballoon ablation for Barrett esophagus-related neoplasia: a prospective European multicenter study

Charlotte N Frederiks iD, Anouk Overwater, Torsten Beyna iD, Horst Neuhaus, Raf Bisschops iD, Roos E Pouw, Jacques J G H M Bergman, Maximilien Barret, Roberta Maselli, Vinay Sehgal, Rehan J Haidry, Bas L A M Weusten iD

Endoscopy · 01.04.2026 · 58 (04) · 323-333

DOI: 10.1055/a-2710-6551 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Endoscopy, erschienen am 01.04.2026. Verfasst von Charlotte N Frederiks und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Barrett Esophagus, Cryosurgery, Esophageal Neoplasms, Esophagoscopy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pentax Medical.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Focal cryoballoon ablation (FCBA) is a relatively new modality for treatment of Barrett esophagus (BE)-related neoplasia. This study evaluated the efficacy and safety of FCBA for BE. Patients with BE segments (Prague classification C≤2M≤5) with dysplasia or early cancer were eligible for inclusion. Following endoscopic resection of visible lesions, FCBA was performed at 3-month intervals until complete eradication of BE (maximum five sessions). After ≥2 FCBA sessions, add-on treatment was allowed. Follow-up endoscopy was scheduled at 6 months and annually thereafter. Outcomes were complete eradication of endoscopically visible BE (CE-BE), intestinal metaplasia (CE-IM), and dysplasia (CE-D), durability of treatment response, and adverse events. 107 patients (mean age 65 years, 91 males, median BE C0M2) were included. Endoscopic resection was performed at entry in 65% (69/107). Patients received a median of 2 FCBA treatments. Add-on treatment was performed in 40% (43/107), mainly APC for small remaining islands (38%; 41/107). CE-BE and CE-D were achieved in 94% (101/107; 95%CI 90%–98%) and CE-IM in 91% (97/107; 95%CI 85%–95%), per intention-to-treat analysis. In per-protocol analysis, CE-BE and CE-D was achieved in 100% (101/101; 95%CI 100%–100%), and CE-IM in 96% (97/101; 95%CI 92%–99%). After a median follow-up of 18 months, 96% (97/101; 95%CI 92%–99%) remained free of endoscopically visible BE. Esophageal stricture was the most common adverse event, in 13% (13/101; 95%CI 6%–20%). FCBA was highly effective in selected patients with BE of limited length, although the potential risk for stricture formation warrants further research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Barrett EsophagusCryosurgeryEsophageal NeoplasmsEsophagoscopyAdenocarcinomaHumansMaleAgedFemaleProspective StudiesMiddle AgedTreatment OutcomeEurope

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Department of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • Department of Internal Medicine and Gastroenterology, Evangelical Hospital Dusseldorf, Düsseldorf, Germany.
  • Department of Gastroenterology and Hepatology, University Hospital Gasthuisberg Leuven, KU Leuven, Leuven, Belgium.
  • Translational Research Center for Gastrointestinal Disorders, KU Leuven, Leuven, Belgium.
  • Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

ORCID-Profile: Charlotte N Frederiks, Torsten Beyna, Raf Bisschops, Bas L A M Weusten

Förderung

  • Pentax Medical

Zitieren

APA

Frederiks, C. N., Overwater, A., Beyna, T., Neuhaus, H., Bisschops, R., Pouw, R. E., Bergman, J. J. G. H. M., Barret, M., Maselli, R., Sehgal, V., Haidry, R. J., & Weusten, B. L. A. M. (2026). Endoscopic eradication therapy with multifocal cryoballoon ablation for Barrett esophagus-related neoplasia: a prospective European multicenter study. Endoscopy, 58(04), 323-333. https://doi.org/10.1055/a-2710-6551

Vancouver

Frederiks CN, Overwater A, Beyna T, Neuhaus H, Bisschops R, Pouw RE, et al. Endoscopic eradication therapy with multifocal cryoballoon ablation for Barrett esophagus-related neoplasia: a prospective European multicenter study. Endoscopy. 2026;58(04):323-333. doi:10.1055/a-2710-6551

BibTeX
@article{Frederiks2026,
  author = {Frederiks, Charlotte N and Overwater, Anouk and Beyna, Torsten and Neuhaus, Horst and Bisschops, Raf and Pouw, Roos E and Bergman, Jacques J G H M and Barret, Maximilien and Maselli, Roberta and Sehgal, Vinay and Haidry, Rehan J and Weusten, Bas L A M},
  title = {Endoscopic eradication therapy with multifocal cryoballoon ablation for Barrett esophagus-related neoplasia: a prospective European multicenter study},
  journal = {Endoscopy},
  year = {2026},
  volume = {58},
  number = {04},
  pages = {323--333},
  doi = {10.1055/a-2710-6551}
}
Kostenlos starten →